Blood-brain barrier genomics, proteomics, and new transporter discovery

NeuroRx

Volumn 2, Issue 1, 2005, Pages 151-161

  Shusta, Eric V ^a  

^a University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANION TRANSPORT PROTEIN; COMPLEMENTARY DNA; LUTHERAN PROTEIN; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; ORGANIC ANION TRANSPORTER; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

BLOOD BRAIN BARRIER; CELL TYPE; DNA MICROARRAY; DRUG TRANSPORT; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC CODE; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; INTERMETHOD COMPARISON; NEUROLOGIC DISEASE; NONHUMAN; PARENCHYMA; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION;

EID: 12344336803     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1602/neurorx.2.1.151     Document Type: Article

References (49)

1. Pardridge WM. CNS drug design based on principles of blood-brain barrier transport. J Neurochem 70:1781-1792, 1998.
2. Boado RJ, Pardridge MM. A one-step procedure for isolation of poly(A)+ mRNA from isolated brain capillaries and endothelial cells in culture. J Neurochem 57:2136-2139, 1991.
3. Shusta EV, Boado RJ, Mathern GW, Pardridge WM. Vascular genomics of the human brain. J Cereb Blood Flow Metab 22:245-252, 2002.
4. Song L, Pachter JS. Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins. In Vitro Cell Dev Biol Anim 39:313-320, 2003.
5. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 291:1304-1351, 2001.
6. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 409:860-921, 2001.
7. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470, 1995.
8. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93:6025-6030, 1996.
9. Li JY, Boado RJ, Pardridge WM. Blood-brain barrier genomics. J Cereb Blood Flow Metab 21:61-68, 2001.
10. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 270:484-487, 1995.
11. Li JY, Boado RJ, Pardridge WM. Rat blood-brain barrier genomics. II. J Cereb Blood Flow Metab 22:1319-1326, 2002.
12. Enerson BE, Drewes LR. The rat blood-brain barrier transcriptome. Brain03, XXIst International Symposium on Cerebral Blood Flow, Metabolism, and Function, 2003.
13. Morita K, Sasaki H, Furuse M, Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147:185-194, 1999.
14. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-660, 2003.
15. Nasdala I, Wolburg-Buchholz K, Wolburg H, Kuhn A, Ebnet K, Brachtendorf G, et al. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J Biol Chem 277:16294-16303, 2002.
16. Kupprion C, Motamed K, Sage EH. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273:29635-29640, 1998.
17. Guardavaccaro D, Corrente G, Covone F, Micheli L, D'Agnano I, Starace G, et al. Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 20:1797-1815, 2000.
18. Couet J, Belanger MM, Roussel E, Drolet MC. Cell biology of caveolae and caveolin. Adv Drug Deliv Rev 49:223-235, 2001.
19. Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 68:41-56, 2000.
20. Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H, et al. Functional characterization of rat brain-specific organic anion transporter (Oatpl4) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem 278:43489-43495, 2003.
21. Huminiecki L, Bicknell R. In silico cloning of novel endothelial-specific genes. Genome Res 10:1796-1806, 2000.
22. Huminiecki L, Lloyd AT, Wolfe KH. Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap, and Tissuelnfo databases. BMC Genomics 4:31, 2003.
23. Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, Stanimirovic DB. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J 17:2085-2087, 2003.
24. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720-1730, 1999.
25. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533-537, 1997.
26. Santoni V, Molloy M, Rabilloud T. Membrane proteins and proteomics: un amour impossible? Electrophoresis 21:1054-1070, 2000.
27. Shusta EV, Boado RJ, Pardridge WM. Vascular proteomics and subtractive antibody expression cloning. Mol Cell Proteom 1:75-82, 2002.
28. Shusta EV, Li JY, Boado RJ, Pardridge WM. The Ro52/SS-A autoantigen has elevated expression at the brain microvasculature. Neuroreport 14:1861-1865, 2003.
29. Shusta EV, Zhu C, Boado RJ, Pardridge WM. Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. J Neuropathol Exp Neurol 61:597-604, 2002.
30. Udani M, Zen Q, Cottman M, Leonard N, Jefferson S, Daymont C, et al. Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest 101:2550-2558, 1998.
31. Zen Q, Cottman M, Truskey G, Fraser R, Telen MJ. Critical factors in basal cell adhesion molecule/Lutheran-mediated adhesion to laminin. J Biol Chem 274:728-734, 1999.
32. Boado RJ, Li JY, Pardridge WM. Selective Lutheran glycoprotein gene expression at the blood-brain barrier in normal brain and in human brain tumors. J Cereb Blood Flow Metab 20:1096-1102, 2000.
33. Hsu EC, Sarangi F, Iorio C, Sidhu MS, Udem SA, Dillehay DL, et al. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol 72:2905-2916, 1998.
34. Cattaneo R, Rebmann G, Baczko K, ter Meulen V, Billeter MA. Altered ratios of measles virus transcripts in diseased human brains. Virology 160:523-526, 1987.
35. Govoni M, Padovan M, Rizzo N, Trotta F. CNS involvement in primary Sjogren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs 15:597-607, 2001.
36. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology (Oxford) 41:605-618, 2002.
37. Kirsch T, Wellner M, Luft FC, Haller H, Lippoldt A. Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats. Brain Res 910:106-115, 2001.
38. Fornage M, Swank MW, Boerwinkle E, Doris PA. Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility. Physiol Genom 15:75-83, 2003.
39. Zhu Z, Zhao B, Wang X, Zhu S, Zhang Q, Xu Y, et al. Differentially expressed genes in hypertensive rats developing cerebral ischemia. Life Sci 74:1899-1909, 2004.
40. Dhodda VK, Sailor KA, Bowen KK, Vemuganti R. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 89:73-89, 2004.
41. Godard S, Getz G, Delorenzi M, Farmer P, Kobayashi H, Desbaillets I, et al. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 63:6613-6625, 2003.
42. Khatua S, Peterson KM, Brown KM, Lawlor C, Santi MR, LaFleur B, et al. Overexpression of the EGFR/FKBP12/HIF-2α pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res 63:1865-1870, 2003.
43. Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly T Jr, Stewart CL, et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54:410-423; discussion 423-435, 2004.
44. Mirnics ZK, Mirnics K, Terrano D, Lewis DA, Sisodia SS, Schor NF. DNA microarray profiling of developing PS1-deficient mouse brain reveals complex and coregulated expression changes. Mol Psychiatry 8:863-878, 2003.
45. Khodarev NN, Labay E, Darga T, Yu J, Mauceri H, Gupta N, et al. Endothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis. Int J Cancer 109:214-219, 2004.
46. Wary KK, Thakker GD, Humtsoe JO, Yang J. Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol Cancer 2:25, 2003.
47. Franzen B, Duvefelt K, Jonsson C, Engelhardt B, Ottervald J, Wickman M, et al. Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-α. Brain Res Mol Brain Res 115:130-146, 2003.
48. Doran KS, Liu GY, Nizet V. Group B streptococcal β-hemolysin/ cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest 112:736-744, 2003.
49. Dombrowski SM, Desai SY, Marroni M, Cucullo L, Goodrich K, Bingaman W, et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42:1501-1506, 2001.